Form 8-K - Current report:
SEC Accession No. 0001193125-25-080856
Filing Date
2025-04-15
Accepted
2025-04-15 09:00:18
Documents
15
Period of Report
2025-04-14
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d943368d8k.htm   iXBRL 8-K 32629
2 EX-3.1 d943368dex31.htm EX-3.1 7854
  Complete submission text file 0001193125-25-080856.txt   211520

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sclxw-20250414.xsd EX-101.SCH 4450
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sclxw-20250414_def.xml EX-101.DEF 14265
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclxw-20250414_lab.xml EX-101.LAB 23901
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclxw-20250414_pre.xml EX-101.PRE 15299
18 EXTRACTED XBRL INSTANCE DOCUMENT d943368d8k_htm.xml XML 6340
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 25837744
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)